Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development
Open Pre-Solicitation Posted
- Solicitation number
- NCI-DCTD-27-0001
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Place of performance
- Rockville, Maryland 20850, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute's Drug Synthesis and Chemistry Branch, within the Developmental Therapeutics Program of the Division of Cancer Treatment and Diagnosis, is conducting market research through a Sources Sought Notice for support services to operate and maintain the NCI Chemotherapeutic Agents Repository (NCI-CAR), covering registration, storage, and distribution of chemicals and drugs for pre-clinical discovery evaluation and development. Capability statements are due by 2:00 PM Eastern Time on Monday, November 30, 2026, though the notice's Due Date field lists December 2, 2026. The Set Aside line reads No Set-Aside Used, and the notice states that all small business set-aside categories will be considered if an RFP is issued.
If an RFP follows, the anticipated vehicle is an IDIQ over five years with cost-reimbursement or firm-fixed-price task orders and an anticipated start date of February 15, 2028. Distribution extends to research investigators domestically and internationally. The repository holds approximately 500,000 to 600,000 samples and must support storage at ambient, 0-5C, -15 to -20C, and -70 to -80C, with capacity for approximately 550,000 containers. Monthly workload is approximately 400 samples received and registered and 2,500 samples distributed from inventory. Required services include 96-well and 384-well DMSO plating and analytical testing with a 10-working-day turnaround for structure and purity determination. Staffing includes an onsite Project Director/Manager with at least a Bachelor's degree and ten years of relevant experience, plus a Co-Principal Investigator/Acquisitions Manager. Urgent COR data requests require a 30-to-90-minute response during business hours, and standard requests require 24-48 hours. Personnel must be bonded and sign non-disclosure agreements. A relocation requires a transition plan, with the new facility fully operational within 30 days and the inventory safely relocated within 60 days post-award; transition costs are submitted separately in the business proposal.
Capability statements are limited to 20 single-spaced pages in 12-point minimum font and are submitted in MS Word or PDF to Lindsay.tonon@nih.gov and erin.dwyer@nih.gov with subject line NCI-DCTD-27-0001. The draft Statement of Work is attached as Attachment 1. The NAICS code is 541990 with a $16.5 million size standard, and the PSC is R707. The notice does not obligate the Government to award a contract or acknowledge receipt of responses.
Notice text
This Sources Sought Notice is issued as a means of conducting market research to identify any/all parties, to include large and small businesses, having an interest in and the resources to support the requirements for Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development. This is NOT a solicitation for proposals, proposal abstracts, or quotations.
Interested parties are expected to review this notice and the draft Statement of Work (SOW) to familiarize themselves with the requirement of this project; failure to do so will be at your firm’s own risk.
The Drug Synthesis and Chemistry Branch (DSCB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) is seeking support services to operate and maintain the National Cancer Institute’s Chemotherapeutic Agents Repository (NCI-CAR). This acquisition is responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to repository activities; and reacquisition of samples for continued chemical and biological studies. Towards this goal, the Program acquires and evaluates about 5,000 single agents each year in anticancer assays. In addition, research samples are provided to the general research community both in vialed and plated format. NCI-CAR is responsible for receiving, storage and distribution services along with curating an inventory of approximately 500,000 - 600,000 individual samples and associated chemical, inventory and distribution data. Approximately 400 samples are received monthly, registered and shipped to NCI testing facilities; an additional 2,500 samples are weighed monthly from inventory and shipped to research investigators both in the U.S. (including NCI) and foreign countries.
The purpose of this Sources Sought Notice is to identify all potentially capable, interested sources. We encourage you to respond to this Sources Sought Notice; particularly if you are a small business. All Small Business Set-Aside categories will be considered.
As a result of this Sources Sought notice, the NCI may issue a Request for Proposal (RFP). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claim against the NCI shall arise as a result of a response to this Sources Sought Notice or the NCI’s use of such information as either part of our evaluation process or in developing specification for any subsequent requirement.
Files
| File | Type | Posted |
|---|---|---|
| Att 1-IDIQ SOW draft.doc | DOC document | |
| Sources Sought Notice Final.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity